Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dietary restriction before irinotecan in patients with liver metastases
NL-OMON29351Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of irinotecan in colorectal cancer (CRC) and Nonhematologic neoplasms (2 arms), sponsored by Erasmus MC. Started Jun 2016; status: active, not recruiting.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON29351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29351.